CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma.
Hong J, Hu K, Yuan Y, Sang Y, Bu Q, Chen G, Yang L, Li B, Huang P, Chen D, Liang Y, Zhang R, Pan J, Zeng YX, Kang T.
Hong J, et al. Among authors: zeng yx.
J Clin Invest. 2012 Jun;122(6):2165-75. doi: 10.1172/JCI61380. Epub 2012 May 15.
J Clin Invest. 2012.
PMID: 22585575
Free PMC article.
Clinical Trial.